drugset / Trial / NCT02774811

Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication

NCT02774811 ↗

RandomizedSingle-groupOpen-labelTreatment

Summary

Multi-centre randomised controlled trial of selective laser trabeculoplasty compared with prostaglandin analogue therapy as primary treatment for high tension open angle glaucoma. Participating centres are: Institute of Ophthalmology, UCL, London, UK McCord Hospital, Durban, South Africa Innovation Eye Centre, Kisii, Kenya

Timeline

Start
2014-02
Primary completion
2019-01
Completion
2019-01

Outcome

Outcome not reported

Stopped: “Unable to maintain a functional laser in the environment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimatoprost Other / unclassified — Topical

Indications